Form 4: Stoke Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Barry Ticho, CHIEF MEDICAL OFFICER of Stoke Therapeutics, Inc., sold 7,176 shares of common stock on August 3, 2026.
Summary
- Open-market sale: disposed of 5,907 Common Stock at $28.95 ($171,008) on August 3, 2026; holds 21,691 after (Direct).
- Open-market sale: disposed of 1,269 Common Stock at $29.45 ($37,377) on August 3, 2026; holds 20,422 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $208,385 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Barry Ticho — Officer (CHIEF MEDICAL OFFICER)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Open-market sale | Common Stock | 5,907 | $29 | $171.0K | 21,691 |
| 2026-08-03 | Open-market sale | Common Stock | 1,269 | $29 | $37.4K | 20,422 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Open-market sale (5,907 shares) |
| 2026-08-03 | Open-market sale (1,269 shares) |
Keywords
insider transaction, Form 4, STOK, Stoke Therapeutics, Inc., bearish, Barry Ticho
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.